
Am J Psychiatry 163:1199-1201, July 2006
doi: 10.1176/appi.ajp.163.7.1199
© 2006 American Psychiatric Association
Impact of Lamotrigine and Lithium on Weight in Obese and Nonobese Patients With Bipolar I Disorder
Charles L. Bowden, M.D.,
Joseph R. Calabrese, M.D.,
Terence A. Ketter, M.D.,
Gary S. Sachs, M.D.,
Robin L. White, M.S., and
Thomas R. Thompson, M.D.
OBJECTIVE: This study assessed weight changes in a large cohort of patients with bipolar disorder who were treated with randomly assigned maintenance monotherapies. METHOD: A post hoc analysis was conducted to assess the effects of lamotrigine, lithium, and placebo administration on body weight in obese and nonobese patients with bipolar disorder from two double-blind, placebo-controlled, 18-month studies. RESULTS: Mean changes in weight among obese patients (N=155) at week 52 were 4.2, +6.1, and 0.6 kg with lamotrigine, lithium, and placebo, respectively (lamotrigine versus lithium and lithium versus placebo). Among nonobese patients (N=399), mean changes in weight (kg) at week 52 were 0.5, +1.1, and +0.7 with lamotrigine, lithium, and placebo, respectively, with no significant differences among groups. CONCLUSIONS: Obese patients with bipolar I disorder lost weight while taking lamotrigine and gained weight while taking lithium.
This article has been cited by other articles:

|
 |

|
 |
 
Reference List for FOCUS Self-Assessment Examination
PsychiatryOnline CME,
October 10, 2007;
2007(3):
2 - 2.
[Full Text]
|
 |
|

|
 |

|
 |
 
Bibliography BIPOLAR DISORDER
Focus,
January 1, 2007;
5(1):
40 - 43.
[Full Text]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2006
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|